Peregrine Pharma (PPHM) Tops Q1 EPS by 6c, Beats on Revenues

September 11, 2017 4:08 PM EDT

Peregrine Pharma (NASDAQ: PPHM) reported Q1 EPS of ($0.06), $0.06 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $27.07 million versus the consensus estimate of $15.2 million.

For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings